$8.68M in early researcher awards announced in Ontario | Laboratory Product News
UNIVERSITY OF WATERLOO
Project
title: Rational design of novel surface active compound for improving
non-viral DNA transfection efficiencies. Lead researcher: Dr Shawn
Wettig. Gene therapy uses DNA to treat disease. While it shows great
promise, creating a delivery system to deliver DNA to specific areas in
the body is a challenge. Dr Wettig is working to develop delivery
systems, starting with one for ovarian cancer, the leading cause of
death among gynecological cancers.
An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.
“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.